SCHEMBL75984

SCHEMBL75984

N#CC1(N)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20987612 0.97 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL56064 0.97
SCHEMBL20987611 0.97 ALDH1A1 (0.46)
SCHEMBL420103 0.97
SCHEMBL4355800 0.97 ALDH1A1 (0.46)
SCHEMBL23311387 0.97 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL696355 0.94 ALDH1A1 (0.43)
SCHEMBL1139426 0.93
Hydrochloric Acid SCHEMBL695268 0.90
SCHEMBL696010 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102491970-B Synthetic method for irbesartan HEFEI UNIVERSITY OF TECHNOLOGY (CN) 2014-10-08 CN claimed
CN-102491970-A Synthetic method for irbesartan UNIV HEFEI TECHNOLOGY 2012-06-13 CN claimed
CN-102050761-A Key intermediate of Erbesartan, synthesis method thereof and method for synthesizing Erbesartan therefrom JIANGSU JIANGSHEN PHARMACEUTICAL CHEMICAL CO LTD 2011-05-11 CN claimed
CN-100413853-C Synthetic intermediate of Irbesartan, preparation method and use thereof ZHEJIANG HISUN PHARMACEUTICAL (CN) 2008-08-27 CN claimed
EP-1799639-A1 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION Glenmark Pharmaceuticals S.A. (CH) 2007-06-27 EP claimed
CN-1919841-A Synthetic intermediate of Irbesartan, preparation method and use thereof ZHEJIANG HISUN PHARMACEUTICAL (CN) 2007-02-28 CN claimed
WO-2006040625-A1 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2006-04-20 WO claimed
US-6936606-B2 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-08-30 US claimed
EP-1434769-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-07-07 EP claimed
US-20040063679-A1 Compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS INC. 2004-04-01 US claimed
WO-2003029200-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-04-10 WO claimed
US-4767757-A Acyloxythiophene-carboxamide fungicides, compositions and use BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US claimed
EP-0241735-A2 Acyloxythiophene carbon amide BAYER AG (DE) 1987-10-21 EP claimed
US-20250333385-A1 DIARYLHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-10-30 US disclosed
US-20240132452-A1 DIARYLHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-25 US disclosed
WO-2023224963-A1 DUAL-ACTING ANGIOTENSIN AND ENDOTHELIN RECEPTOR ANTAGONISTS ARIA PHARMACEUTICALS, INC. (US) 2023-11-23 WO disclosed
EP-0241735-A2 Acyloxythiophene carbon amide BAYER AG (DE) 1987-10-21 EP disclosed
US-4650516-A PLANT SAFENING AGENTS STAUFFER CHEMICAL CO. (US) 1987-03-17 US disclosed
US-4058662-A Process for the substitution of chlorine atoms of cyanuric chloride DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-11-15 US disclosed
US-4054739-A Process for the substitution of chlorine atoms of cyanuric chloride DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-10-18 US disclosed